Publication
TGA shelves biosimilar and generic transparency measures
In late 2020, following almost 18 months of public and industry consultations conducted by the Therapeutic Goods Administration (TGA).
United States | Publication | October 21, 2021
Despite its ancient origins, recent Commercial Division decisions illustrate how the flexible canon of ejusdem generis continues to shape the interpretation of modern contracts, as well as statutes, frequently serving as a limiting principle on a litigant’s expansive interpretation of a contract’s or statute’s catchall phrase. Thomas J. Hall and Judith A. Archer explore the term in this edition of their Commercial Division Update.
Download the full New York Law Journal article, "Ejusdem generis: It is known by the company it keeps."
Publication
In late 2020, following almost 18 months of public and industry consultations conducted by the Therapeutic Goods Administration (TGA).
Publication
The NSW Environment Protection Authority (EPA) recently released for public comment its draft Climate Change Assessment Requirements (CCARs) and draft Guide for Large Emitters (Guide).
Publication
The introduction of a minimum stockholding obligation under the Fuel Security Act 2021 (Cth) has underscored the importance of traditional liquid fuels to safeguarding Australia’s energy security as it navigates the energy transition.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2023